Cellectis S.A.
CLLS · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$36,696 | -$116,835 | -$98,688 | -$96,749 |
| Dep. & Amort. | $19,839 | $18,523 | $18,435 | $14,156 |
| Deferred Tax | $0 | $371 | $87 | $0 |
| Stock-Based Comp. | $0 | $5,233 | $6,043 | $11,493 |
| Change in WC | $53,570 | -$3,986 | -$5,723 | -$12,297 |
| Other Non-Cash | -$14,610 | $71,948 | -$7,598 | -$21,165 |
| Operating Cash Flow | $22,103 | -$24,746 | -$87,444 | -$104,562 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$3,836 | -$1,073 | -$2,431 | -$18,543 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$162,483 | $0 | $0 | -$143 |
| Inv. Sales/Matur. | $63,693 | $0 | $126 | $15,000 |
| Other Inv. Act. | $0 | -$14,437 | -$456 | $10,965 |
| Investing Cash Flow | -$102,626 | -$15,510 | -$2,761 | $7,279 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $18,168 | $24,564 | -$6,604 | -$10,641 |
| Stock Issued | $82,676 | $67,936 | $0 | $44,638 |
| Stock Repurch. | $0 | $0 | -$569 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$11,042 | -$9,635 | $8,318 | $13,528 |
| Financing Cash Flow | $89,801 | $82,865 | $1,145 | $47,525 |
| Forex Effect | -$2,735 | $884 | -$3,360 | -$5,754 |
| Net Chg. in Cash | $6,543 | $43,492 | -$92,420 | -$55,512 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $136,708 | $93,216 | $185,636 | $241,148 |
| End Cash | $143,251 | $136,708 | $93,216 | $185,636 |
| Free Cash Flow | $19,524 | -$25,819 | -$89,885 | -$123,118 |